by Thomas Dworetzky
, Contributing Reporter | April 14, 2015
European medical device sector investments are on the rise, according to a new survey.
Technologies that drive cost efficiency are especially hot, according to a new report from Frost & Sullivan. Cuts to reimbursements as well as health care costs are partially driving the trends, it revealed.
That said, investors are shifting from early-stage to late-stage startups as failure rates and investments rise and exit options drop.
Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs
"Mergers and acquisitions (M&As) will be the primary exit options for companies in the European medical device sector," said Frost & Sullivan Senior Financial Analyst Saneesh Edacherian.
U.S. buyers to M&As in Europe are also expected to increase, stated the report.
The report suggested that pricing pressures and lower returns on in-house R&D will force major participants in the European medical device industry to look for strategic acquisitions to boost therapeutic pipelines.
"This trend is primarily a result of reducing margins, regulatory uncertainty, and depleting pipelines that force top pharmaceutical enterprises to look for diversification in the European market," said Edacherian.